Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
COO vs HOLX
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
COO vs HOLX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Market Cap | $11.97B | $16.97B |
| Revenue (TTM) | $4.15B | $4.13B |
| Net Income (TTM) | $401M | $544M |
| Gross Margin | 64.2% | 52.8% |
| Operating Margin | 17.2% | 17.5% |
| Forward P/E | 13.2x | 17.2x |
| Total Debt | $2.78B | $2.63B |
| Cash & Equiv. | $111M | $1.96B |
COO vs HOLX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| The Cooper Companie… (COO) | 100 | 77.1 | -22.9% |
| Hologic, Inc. (HOLX) | 100 | 142.6 | +42.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: COO vs HOLX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
COO is the clearest fit if your priority is growth exposure.
- Rev growth 5.1%, EPS growth -4.6%, 3Y rev CAGR 7.3%
- 5.1% revenue growth vs HOLX's 1.7%
- Lower P/E (13.2x vs 17.2x)
HOLX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 0.41
- 124.3% 10Y total return vs COO's 57.9%
- Lower volatility, beta 0.41, Low D/E 52.0%, current ratio 3.75x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.1% revenue growth vs HOLX's 1.7% | |
| Value | Lower P/E (13.2x vs 17.2x) | |
| Quality / Margins | 13.2% margin vs COO's 9.7% | |
| Stability / Safety | Beta 0.41 vs COO's 0.93 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +37.1% vs COO's -24.8% | |
| Efficiency (ROA) | 6.1% ROA vs COO's 3.2%, ROIC 9.4% vs 4.8% |
COO vs HOLX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
COO vs HOLX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — COO and HOLX each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
COO and HOLX operate at a comparable scale, with $4.2B and $4.1B in trailing revenue. Profitability is closely matched — net margins range from 13.2% (HOLX) to 9.7% (COO). On growth, COO holds the edge at +6.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.2B | $4.1B |
| EBITDAEarnings before interest/tax | $1.0B | $974M |
| Net IncomeAfter-tax profit | $401M | $544M |
| Free Cash FlowCash after capex | $333M | $1000M |
| Gross MarginGross profit ÷ Revenue | +64.2% | +52.8% |
| Operating MarginEBIT ÷ Revenue | +17.2% | +17.5% |
| Net MarginNet income ÷ Revenue | +9.7% | +13.2% |
| FCF MarginFCF ÷ Revenue | +8.0% | +24.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +26.9% | -9.2% |
Valuation Metrics
COO leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 30.5x trailing earnings, HOLX trades at a 7% valuation discount to COO's 32.7x P/E. On an enterprise value basis, COO's 13.2x EV/EBITDA is more attractive than HOLX's 17.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $12.0B | $17.0B |
| Enterprise ValueMkt cap + debt − cash | $14.6B | $17.6B |
| Trailing P/EPrice ÷ TTM EPS | 32.68x | 30.53x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.24x | 17.21x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 13.24x | 17.39x |
| Price / SalesMarket cap ÷ Revenue | 2.93x | 4.14x |
| Price / BookPrice ÷ Book value/share | 1.48x | 3.43x |
| Price / FCFMarket cap ÷ FCF | 27.60x | 18.44x |
Profitability & Efficiency
HOLX leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
HOLX delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $5 for COO. COO carries lower financial leverage with a 0.34x debt-to-equity ratio, signaling a more conservative balance sheet compared to HOLX's 0.52x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs COO's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +4.8% | +11.0% |
| ROA (TTM)Return on assets | +3.2% | +6.1% |
| ROICReturn on invested capital | +4.8% | +9.4% |
| ROCEReturn on capital employed | +6.1% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.34x | 0.52x |
| Net DebtTotal debt minus cash | $2.7B | $667M |
| Cash & Equiv.Liquid assets | $111M | $2.0B |
| Total DebtShort + long-term debt | $2.8B | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | 6.40x | 8.00x |
Total Returns (Dividends Reinvested)
HOLX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HOLX five years ago would be worth $11,582 today (with dividends reinvested), compared to $6,049 for COO. Over the past 12 months, HOLX leads with a +37.1% total return vs COO's -24.8%. The 3-year compound annual growth rate (CAGR) favors HOLX at -2.9% vs COO's -14.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -24.7% | +1.9% |
| 1-Year ReturnPast 12 months | -24.8% | +37.1% |
| 3-Year ReturnCumulative with dividends | -36.7% | -8.5% |
| 5-Year ReturnCumulative with dividends | -39.5% | +15.8% |
| 10-Year ReturnCumulative with dividends | +57.9% | +124.3% |
| CAGR (3Y)Annualised 3-year return | -14.1% | -2.9% |
Risk & Volatility
HOLX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HOLX is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than COO's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs COO's 68.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.93x | 0.41x |
| 52-Week HighHighest price in past year | $89.83 | $76.04 |
| 52-Week LowLowest price in past year | $60.00 | $52.81 |
| % of 52W HighCurrent price vs 52-week peak | +68.0% | +100.0% |
| RSI (14)Momentum oscillator 0–100 | 24.7 | 69.1 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 10.0M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates COO as "Buy" and HOLX as "Hold". Consensus price targets imply 53.6% upside for COO (target: $94) vs 3.9% for HOLX (target: $79).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $93.86 | $79.00 |
| # AnalystsCovering analysts | 24 | 42 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.4% | +4.4% |
HOLX leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). COO leads in 1 (Valuation Metrics). 1 tied.
COO vs HOLX: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is COO or HOLX a better buy right now?
For growth investors, The Cooper Companies, Inc.
(COO) is the stronger pick with 5. 1% revenue growth year-over-year, versus 1. 7% for Hologic, Inc. (HOLX). Hologic, Inc. (HOLX) offers the better valuation at 30. 5x trailing P/E (17. 2x forward), making it the more compelling value choice. Analysts rate The Cooper Companies, Inc. (COO) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — COO or HOLX?
On trailing P/E, Hologic, Inc.
(HOLX) is the cheapest at 30. 5x versus The Cooper Companies, Inc. at 32. 7x. On forward P/E, The Cooper Companies, Inc. is actually cheaper at 13. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — COO or HOLX?
Over the past 5 years, Hologic, Inc.
(HOLX) delivered a total return of +15. 8%, compared to -39. 5% for The Cooper Companies, Inc. (COO). Over 10 years, the gap is even starker: HOLX returned +124. 3% versus COO's +57. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — COO or HOLX?
By beta (market sensitivity over 5 years), Hologic, Inc.
(HOLX) is the lower-risk stock at 0. 41β versus The Cooper Companies, Inc. 's 0. 93β — meaning COO is approximately 127% more volatile than HOLX relative to the S&P 500. On balance sheet safety, The Cooper Companies, Inc. (COO) carries a lower debt/equity ratio of 34% versus 52% for Hologic, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — COO or HOLX?
By revenue growth (latest reported year), The Cooper Companies, Inc.
(COO) is pulling ahead at 5. 1% versus 1. 7% for Hologic, Inc. (HOLX). On earnings-per-share growth, the picture is similar: The Cooper Companies, Inc. grew EPS -4. 6% year-over-year, compared to -25. 0% for Hologic, Inc.. Over a 3-year CAGR, COO leads at 7. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — COO or HOLX?
Hologic, Inc.
(HOLX) is the more profitable company, earning 13. 8% net margin versus 9. 2% for The Cooper Companies, Inc. — meaning it keeps 13. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOLX leads at 17. 4% versus 16. 7% for COO. At the gross margin level — before operating expenses — HOLX leads at 61. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is COO or HOLX more undervalued right now?
On forward earnings alone, The Cooper Companies, Inc.
(COO) trades at 13. 2x forward P/E versus 17. 2x for Hologic, Inc. — 4. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COO: 53. 6% to $93. 86.
08Which pays a better dividend — COO or HOLX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is COO or HOLX better for a retirement portfolio?
For long-horizon retirement investors, Hologic, Inc.
(HOLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41), +124. 3% 10Y return). Both have compounded well over 10 years (HOLX: +124. 3%, COO: +57. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between COO and HOLX?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.